This is biologically plausible, as T-cell effector function relies on oxidative and cholesterol-linked metabolism44, while VEGF blockade enhances vascular normalization and chemokine-mediated infiltration but requires metabolically fit CD8+ T cells to sustain tumor entry45, 46. The gene discussed is VEGFA; the disease is neoplasm.